Immune checkpoint inhibitor topics

Immune checkpoint inhibitors are a new immunotherapy treatment option for advanced non–small-cell lung cancer (NSCLC). Learn more about immune checkpoint inhibitors.

yellow unaunahi on orange background

Immune checkpoint inhibitors for advanced non–small-cell lung cancer

Keytruda (also called pembrolizumab)

Tecentriq (also called atezolizumab)

Imfinzi (also called durvalumab)